Activin and Inhibin

GNE-140 racemate is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. GNE-140 racemate is a potent lactate dehydrogenase A (LDHA) inhibitorIn VitroIncreased glucose consumption distinguishes cancer cells from normal cells and is known as the

GNE-140 racemate is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. GNE-140 racemate is a potent lactate dehydrogenase A (LDHA) inhibitorIn VitroIncreased glucose consumption distinguishes cancer cells from normal cells and is known as the

GNE-140 racemate is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. GNE-140 racemate is a potent lactate dehydrogenase A (LDHA) inhibitorIn VitroIncreased glucose consumption distinguishes cancer cells from normal cells and is known as the

GNE-140 racemate is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. GNE-140 racemate is a potent lactate dehydrogenase A (LDHA) inhibitorIn VitroIncreased glucose consumption distinguishes cancer cells from normal cells and is known as the

GNE-140 racemate is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. GNE-140 racemate is a potent lactate dehydrogenase A (LDHA) inhibitorIn VitroIncreased glucose consumption distinguishes cancer cells from normal cells and is known as the

GNE-140 racemate is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. GNE-140 racemate is a potent lactate dehydrogenase A (LDHA) inhibitorIn VitroIncreased glucose consumption distinguishes cancer cells from normal cells and is known as the

GNE-149 is an orally bioavailable full antagonist of estrogen receptor α ( ERα : IC 50 =0.053 nM). GNE-149 is a selective estrogen receptor degrader (SERD). GNE-149 can be used for the research of breast cancerIn VitroGNE-149 exhibits

GNE-149 is an orally bioavailable full antagonist of estrogen receptor α ( ERα : IC 50 =0.053 nM). GNE-149 is a selective estrogen receptor degrader (SERD). GNE-149 can be used for the research of breast cancerIn VitroGNE-149 exhibits

GNE-149 is an orally bioavailable full antagonist of estrogen receptor α ( ERα : IC 50 =0.053 nM). GNE-149 is a selective estrogen receptor degrader (SERD). GNE-149 can be used for the research of breast cancerIn VitroGNE-149 exhibits

GNE-1858 is a potent and ATP-competitive hematopoietic progenitor kinase-1 (HPK1) inhibitor, with IC 50 s of 1.9 nM, 1.9 nM, and 4.5 nM for wild-type and the active mimetic mutants HPK1-TSEE and HPK1-SA, respectively.In VitroHematopoietic progenitor

GNE-1858 is a potent and ATP-competitive hematopoietic progenitor kinase-1 (HPK1) inhibitor, with IC 50 s of 1.9 nM, 1.9 nM, and 4.5 nM for wild-type and the active mimetic mutants HPK1-TSEE and HPK1-SA, respectively.In VitroHematopoietic progenitor

GNE-1858 is a potent and ATP-competitive hematopoietic progenitor kinase-1 (HPK1) inhibitor, with IC 50 s of 1.9 nM, 1.9 nM, and 4.5 nM for wild-type and the active mimetic mutants HPK1-TSEE and HPK1-SA, respectively.In VitroHematopoietic progenitor